FDA Inspection 1226061 — Scribe Manufacturing, Inc.
The FDA completed an inspection of Scribe Manufacturing, Inc. on Nov 30, 2023 in Red Wing, MN. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Nov 30, 2023
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Red Wing, MN (United States)